BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Wlcus - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Wlcus
X-ORIGINAL-URL:https://wlcus.com
X-WR-CALDESC:Events for Wlcus
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20261021T080000
DTEND;TZID=UTC:20261022T170000
DTSTAMP:20261103T094034Z
CREATED:20251116T140429Z
LAST-MODIFIED:20261103T094034Z
UID:15028-1792569600-1792688400@wlcus.com
SUMMARY:European RWE & Market Access Summit 2026
DESCRIPTION:European RWE & Market AccessSummit 2026\nJCA & PICO Strategy Edition\nOctober 21-22  |  Amsterdam\nInntel Hotels Amsterdam Landmark\nRequest Agenda\nRegister Now\nRegister Now !\nRequest Agenda\nRegister Now\n2026 Strategic Focus\nWhy This Summit is the Industry’s Definitive "Don’t-Miss" Briefing\nJCA Submission Mastery\nNavigate the high-stakes transition into mandatory Joint Clinical Assessments with a tactical roadmap for oncology and ATMP dossiers. Gain the "how-to" on meeting aggressive timelines and ensuring your evidence package is fully compliant with the new 100-day submission window.\nPICO Scoping & Strategy\nEliminate "PICO anxiety" by learning predictive frameworks to anticipate the Population\, Intervention\, Comparator\, and Outcome requirements of diverse Member States. Master the art of bias mitigation and statistical alignment to prevent costly delays in your submission process.\nDARWIN EU 2.0 Operations\nGet a direct technical briefing on the EMA’s DARWIN EU network and its transformative role in multi-state data interoperability. Learn to generate "regulatory-grade" evidence that meets the highest standards of data quality and scientific integrity for 2026–2028.\nNational HTA Alignment\nSolve the challenge of national divergence by aligning global RWE strategies with the specific priorities of local payers and HTA bodies. Transition from broad data collection to precision evidence that addresses country-specific pricing and reimbursement hurdles.\nAI-Driven Evidence Synthesis\nExplore the commercial integration of AI and machine learning to streamline RWE operations and automate complex data synthesis. Discover how to reduce the "data-to-submission" lifecycle\, providing your cross-functional teams a competitive edge in rapid-response environments.\nPayer & Regulator Networking\nBreak down organizational silos by engaging in closed-door discussions with the key architects of the European HTA landscape. Build the high-level networks necessary to influence policy\, understand payer sentiment\, and secure long-term market sustainability for your pipeline.\nJoin the Summit on October 21-22 in Amsterdam\, Netherlands\nPharmaceutical Companies\nBio-Pharma Companies\nRWE / HEOR Directors & Leads\nMarket Access Directors & Senior Managers\nPricing & Reimbursement Leaders\nMedical Affairs\nEvidence Strategy Teams\nRegulatory Strategy Teams\nHTA Assessors\nReal World Data - RWD\nReal World Evidence - RWE\nPayer Decision Makers\nPolicy Makers\nEvidence Reviewers\nAI in HealthCare Experts\nRWD Platform Providers\nDigital Therapeutics Companies\nFederated Data Networks\nEvidence Technology Innovators\nHEOR Modelling Experts\nEvidence Specialists\nHealth Economists\nAccess Researchers\nOur RWE & Pricing Event 2026\, Stats:\nSpeakers\nProfessionals & Leaders\nCountries\nMeet the Conference Speakers & Thought Leaders\nOur Prestigious Panel of Speakers\nThe Chair\nDr. Vivian Mendonca\nSVP- Global Head - Commercial\nStrategy\, Access\, Pricing\, HEOR\,\nCDx\, Policy and Patient\nEngagement\nMENARINI Group\nElena Petelos\nVice President \nHealth Technology Assessment\nEuropean Public Health Association\nCharlotte Litrowski\nHead of Market Access & Pricing  EMEA / RoW\nSERB Pharmaceuticals\nDr. Magda Chatzikou\nHTA & RWE Strategist ofDigital Health\nPharmaecons Easy Access\nDr. Marco Penske\nHead of Market Access &  Healthcare Affairs\nBoehringer Ingelheim\nYvette Venable\nHead of EUCAN Market Access\nAstraZeneca\nDiana Sinkevich\nVP\, Access and Global HEOR \nGlobal Rare Diseases\nChiesi Group\nDr. Natalie Steck\nInternational HTA Strategy\n& Policy Director\nMSD\nCatia Proenca\nEU-HTADirector\nBayer\nAnke Sieg\nHead of JCA  HTA\n& Payer\nU C B\nFabian Schmidt\nGlobal Head of Value & Access  and Policy\nRecordati Rare Disease\nDr. Sofie Gustafsson\nGlobal Director\, RWE Partnerships & Innovation (Intl. Markets)\nPfizer\nHélène Karcher\nEvidence Solution Leader\nROCHE\nCarolin Knorr-Hendreich\nPrincipal Consultant  HTA\n& Market Access\nDLRC Group\nRonald Vollebregt\nReal World Data  Manager\nAMGEN\nDr. Katrin Kupas\nSr. Director\, Head of\nRWE Oncology\nMerck Healthcare\nDr. Burçak Aydın\nDirector\, Deloitte Strategy Value & Access Team\nDeloitte\nDr. Debarshi Dey\, PhD.\nVice PresidentHead of Data Science\nLakefront\nStefano Marino\nFormer head of  Legal Department\nEx - E M A\nRosemary Jose Haaksman\nFounder  & Consultant\nBridges2Access\nAndrea Bilgeri\nHead of Value and Access Specialty Medicine Europe\nDaiichi Sankyo\nLora Fleifel\nMarket Access and Pricing Operations Director- Specialty care and Rare Tumors- Europe\nMerck Healthcare\nDr. Deepti Tayal\nChief Executive Officer  CEO\nIngenious e-Brain Solutions\nFelix Steinbrenner\nCo-Founder  Co-CEO\nCellbyte\nErik Alferink\nDirector\, Health Economics\, Market\nAccess\, and Reimbursement\n(HEMAR) Hospital Patient Monitoring\nPhilips\nNandia Gogozotou\nPresident of the Innovation Fund\nCommittee & President of the Drug\nPrice Negotiation Committee\nGreek MInistry of Health\nMounia Chabane\nCo-Founder and Global Head  Research & Development\nI A R O D\nRavi Jandhyala\nConsultant Pharmaceutical Physician\nMedialis Ltd.\nJoin the EU moment Now!\nEvent 2026 Sponsors\, Exhibitors & Partners\nDLRC Group\nCellbyte\nIngenious e-Brain\nVelora Evidence\nBridge2Access\nDLRC Group is a leading life sciences consultancy specializing in Regulatory Affairs\, HTA\, and Market Access strategy for pharmaceutical\, biotechnology\, medical device\, and healthcare companies. With offices in the UK\, Germany\, and the US\, DLRC supports organizations from early development through commercialization and lifecycle management. Their expertise includes regulatory strategy\, evidence planning\, HTA submissions\, reimbursement pathways\, payer engagement\, and market access optimization. DLRC helps clients navigate complex global regulatory and access requirements\, ensuring products reach patients efficiently. Their strong focus on evidence generation\, HTA readiness\, and market access makes them highly relevant to organizations operating within the evolving EU-HTA and Real- World Evidence landscape.\nCellbyte is an AI-native platform helping pharmaceutical companies accelerate global drug launches by transforming complex pricing\, market access\, HTA\, regulatory\, and clinical data into actionable insights. Its intelligent AI agents automate time-consuming workflows\, enabling faster\, more informed decision-making across the product commercialization lifecycle. Trusted by leading pharmaceutical organizations\, Cellbyte empowers Market Access\, HEOR\, Pricing\, and Commercial teams to streamline launch planning\, optimize reimbursement strategies\, and improve cross-functional collaboration. By combining advanced AI with comprehensive\, continuously updated global healthcare data\, Cellbyte enables organizations to reduce manual effort\, enhance strategic planning\, and bring innovative therapies to patients faster across international markets\nIngenious e-Brain Solutions (IEBS) is a global management consulting and intelligence firm with 14+ years of experience supporting leading life sciences and healthcare organizations. We help clients navigate complex RWE\, market access\, HEOR\, HTA\, pricing & reimbursement\, and JCA challenges through deep domain expertise\, advanced analytics\, AI\, and technology. With 5\,000+ engagements and partnerships with 50+ Fortune 500 and Global 2000 organizations\, we combine proven expertise with agile\, scalable delivery. As market access evolves towardfaster evidence generation and more integrated HTA frameworks\, IEBS is transforming its heritage into velocity-using AI\, automation\, and advanced analytics to accelerate insights\, strengthen evidence strategies\, and enable faster\, smarter patient access.\nVelora Evidence is an evidence generation and medical affairs consultancy. We build integrated evidence generation plans through facilitated workshops\, and support the execution of the real-world studies that follow\, whether observational\, registry based\, patient reported\, or drawn from claims and linked health data. We provide strategic and operational oversight from design and protocol through to analysis and publication strategy.\nBridges2Access partners with pharmaceutical\, biotechnology\, and medical technology companies to accelerate patient access through expert support in Market Access\, HEOR\, HTA\, Evidence Generation\, Pricing & Reimbursement\, and Health Policy. With flexible senior-level consulting\, they help organizations develop evidence-based strategies that strengthen value\, support payer engagement\, and improve commercial success.\nRegister Now!\nTickets & Registration\nEuropean\nRWE & Market Access\nSummit 2026\nAmsterdam | Oct. 21-22\n2 + 1 Delegates\n€ 1199\n€ 1999\nBuy Now\nEuropean\nRWE & Market Access\nSummit 2026\nAmsterdam | Oct. 21-22\nSingle Delegate\n€ 599\n€ 999\nBuy Now\nEuropean\nRWE & Market Access\nSummit 2026\nAmsterdam | Oct. 21-22\nSingle Delegate\n€ 1499\n€ 1999\nBuy Now\nIncluded Accommodation\nEuropean\nRWE & Market Access\nSummit 2026\nAmsterdam | Oct. 21-22\nSingle Delegate\n€ 1499\n€ 1999\nBuy Now\nConsultants & Solution Providers\nRelated Videos\nDivider\nWhy RWE Can Make or Break Your Drug Launch\nRWE is Revolutionizing the Pharma Industry\nDrone Technology & Data Insights
URL:https://wlcus.com/event/rwe_market_access_event_2026/
LOCATION:Amsterdam\, Amsterdam\, Netherlands
CATEGORIES:Pharma
ATTACH;FMTTYPE=image/webp:https://wlcus.com/media/2026/11/dad45d7bb9ec78959b5044f3.webp
ORGANIZER;CN="Wlcus":MAILTO:booking@wlcus.com
END:VEVENT
END:VCALENDAR